| 3N2V | date | ![]() |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| authors | |||||||||||||||
| compound | source | ||||||||||||||
| symmetry |
| ||||||||||||||
| crystal cell |
| ||||||||||||||
| method | X-Ray Diffraction | resolution | |||||||||||||
| ligand | CA, JT5, ZN BindingDB | enzyme |
| ||||||||||||
| Gene Ontology |
| ||||||||||||||
| Primary reference | Structure-based approach to nanomolar, water soluble matrix metalloproteinases inhibitors (MMPIs)., Attolino E, Calderone V, Dragoni E, Fragai M, Richichi B, Luchinat C, Nativi C, Eur J Med Chem. 2010 Oct 19. PMID:20965620 | ||||||||||||||
| Data retrieval |
![]() |
| View 3N2V in 3D |
Proteopedia, because life has more than 2D. |
| Structure-derived information |
| Sequence-derived information |
|
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |